Flow cytometric detection of hyper-polarized mitochondria in regulated and accidental cell death processes.


Journal

Apoptosis : an international journal on programmed cell death
ISSN: 1573-675X
Titre abrégé: Apoptosis
Pays: Netherlands
ID NLM: 9712129

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 5 6 2020
medline: 4 6 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

Shikonin induced necroptosis in Jurkat cells were identified flow cytometrically by the up-regulation of RIP3 in live cells and that a proportion of these cells underwent other forms of regulated cell death (RCD) which included parthanatos (< 10%), or cleaved PARP (< 10%) and DNA Damage (> 30%). Live necroptotic cells also possessed functioning mitochondria with hyper-polarized mitochondria membrane potential and generated a fivefold increase in cellular reactive oxygen species (ROS) which was resistant to inhibition by zVAD and necrostatin-1 (Nec-1). After loss of plasma membrane integrity these dead necroptotic cells then showed a higher incidence of parthanatos (> 40%), or cleaved PARP (> 15%) but less DNA Damage (< 15%). Inhibition of shikonin induced apoptosis and necroptosis by zVAD and Nec-1 respectively resulted in live necroptotic cells with an increased incidence of cleaved PARP and reduced levels of DNA Damage respectively. Dead necroptotic cells then showed a reduced incidence of parthanatos and DNA Damage after inhibition by zVAD and Nec-1 respectively. A high proportion of these dead necroptotic cells (30%) which lacked plasma membrane integrity also displayed functioning hyper-polarized mitochondria with high levels of cellular ROS and thus had the capacity to influence the outcome of RCD processes rather than just been the end product of cell death, the necrotic cell. Flow cytometry can thus measure multiple forms of RCD and the level of cellular ROS and MMP which highlights the inter-connection between cell death processes and that a single cell may simultaneously display multiple forms of RCD.

Identifiants

pubmed: 32495124
doi: 10.1007/s10495-020-01613-5
pii: 10.1007/s10495-020-01613-5
pmc: PMC7347690
doi:

Substances chimiques

AGFG1 protein, human 0
Antineoplastic Agents 0
H2AX protein, human 0
Histones 0
Imidazoles 0
Indoles 0
Naphthoquinones 0
Nuclear Pore Complex Proteins 0
Oligopeptides 0
RNA-Binding Proteins 0
Reactive Oxygen Species 0
benzyloxycarbonyl-valyl-alanyl-aspartic acid 0
necrostatin-1 0
shikonin 3IK6592UBW
Poly(ADP-ribose) Polymerases EC 2.4.2.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-557

Références

Mol Cell. 2014 Apr 10;54(1):133-146
pubmed: 24703947
Nat Commun. 2017 Feb 08;8:14329
pubmed: 28176780
Cell Death Differ. 2012 Jan;19(1):107-20
pubmed: 21760595
PLoS One. 2011;6(8):e23209
pubmed: 21853090
Acta Pharmacol Sin. 2017 Nov;38(11):1543-1553
pubmed: 28816233
Front Physiol. 2014 Aug 26;5:323
pubmed: 25206339
Apoptosis. 2018 Jun;23(5-6):299-313
pubmed: 29705943
Immunol Rev. 2017 May;277(1):76-89
pubmed: 28462525
Semin Cell Dev Biol. 2014 Nov;35:14-23
pubmed: 25087983
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Biochim Biophys Acta Mol Cell Res. 2018 Jan;1865(1):132-141
pubmed: 28993228
Biochim Biophys Acta. 2013 Dec;1833(12):3448-3459
pubmed: 23770045
Cell Death Differ. 2017 Jul;24(7):1184-1195
pubmed: 28498367
Microb Cell. 2016 Feb 23;3(3):101-108
pubmed: 28357340
Apoptosis. 2019 Jun;24(5-6):453-464
pubmed: 30788651
Pathol Res Pract. 2018 Nov;214(11):1749-1757
pubmed: 30244947
Semin Cell Dev Biol. 2014 Nov;35:24-32
pubmed: 24582829
Free Radic Biol Med. 2017 Jul;108:433-444
pubmed: 28414098
Genes Dev. 1999 Oct 1;13(19):2514-26
pubmed: 10521396
Methods. 2018 Feb 1;134-135:56-66
pubmed: 29175336
Anal Biochem. 2018 Jul 1;552:50-59
pubmed: 28711444
EMBO J. 2010 May 5;29(9):1585-99
pubmed: 20360685
Cancer Lett. 2017 Apr 1;390:77-90
pubmed: 28108311

Auteurs

G Warnes (G)

Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, 4 Newark Street, London, E1 2AT, UK. g.warnes@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH